כל מה שחשוב לכם במקום אחד

עקבו אחרי פידים: בלוגים, חדשות, RSS ועוד. דרך קלה לקרוא ולהתעדכן בתוכן שאתם בוחרים.

התחילו להשתמש ב-Feeder

פידי RSS של תעשיית התרופות

פידי ה-RSS בנושא תעשיית התרופות שמשתמשי Feeder עוקבים אחריהם הכי הרבה, כולל ClinicalTrials.gov: NCFB | Last update posted in the last 14 days, ClinicalTrials.gov: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days ו-Bayer Global PR | GU. העתיקו כתובת URL של פיד או עקבו אחריהם בחינם ב-Feeder.

נושאים קשורים

פידי RSS של בריאות פידי RSS של אונקולוגיה פידי RSS של ניסויים קליניים פידי RSS של מחקר רפואי פידי RSS של בריאות הנפש פידי RSS של פסיכולוגיה פידי RSS של בריאות הציבור

הצעת עריכה

ClinicalTrials.gov: NCFB | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: NCFB | Last update posted in the last 14 days

ClinicalTrials.gov: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days

Nxera Pharma | IRニュース (Narcolepsy)

investors.nxera.life

ネクセラファーマ Nxera PharmaのIRニュースを掲載しています。

ClinicalTrials.gov: SKB410 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: SKB410 | Last update posted in the last 14 days

ClinicalTrials.gov: CRB-701 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: CRB-701 | Last update posted in the last 14 days

ClinicalTrials.gov: LY4052031 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: LY4052031 | Last update posted in the last 14 days

ClinicalTrials.gov: MK-3120 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: MK-3120 | Last update posted in the last 14 days

ClinicalTrials.gov: AKY-1189 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: AKY-1189 | Last update posted in the last 14 days

ClinicalTrials.gov: Other terms: RSV vaccine | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: RSV vaccine | Last update posted in the last 14 days

ClinicalTrials.gov: Homozygous Familial Hypercholesterolemia | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Homozygous Familial Hypercholesterolemia | Last update posted in the last 14 days

ClinicalTrials.gov: Other terms: Pfizer | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: Pfizer | Last update posted in the last 14 days

ClinicalTrials.gov: Other terms: Sanofi | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: Sanofi | Last update posted in the last 14 days

J&J PR | GU

jnj.com

Explore all Johnson & Johnson published press releases by date and/or topic of news.

Global News | Astellas | GU

newsroom.astellas.com

Explore Astellas’ global press releases and discover the latest news and updates about Astellas.

Bayer | LinkedIn

linkedin.com

Bayer | 6,769,296 followers on LinkedIn. Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population.

Bayer UK | LinkedIn

linkedin.com

Bayer UK | 7,724 followers on LinkedIn. Bayer in the UK | Bayer is a global life science company with core interests in healthcare and agriculture. At Bayer, our mission of “Health for All, Hunger for None” drives our commitment to addressing societal and environmental needs, benefiting people and improving their quality of life. Through research and innovation, we aim to reimagine how we care for ourselves, and one another, by empowering everyday health, improving approaches to patient care,